Financials
Financial year 2025
Geassocieerde Apotheek Schilde from Schilde, company number BE0872283386, closed financial year 2025 with a result of € 58,552 after tax. For that financial year Geassocieerde Apotheek Schilde recorded a gross margin of € 359,772 and equity of € 314,256. Compared with financial year 2024, the result moved from € 73,860 to € 58,552. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.
€ 314,256
▲ 3% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 58,552
▼ 21% vs 2024
Profit after tax over the fiscal year.
€ 14,988
▲ 40% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 50,000 paid out
85 % of the profit went to the shareholders, mostly to AFS (99 % of the shares). That is where the money ends up.
People and assets in 2025
4.1
▲ 0.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 264,111
▼ 15% vs 2024
€ 64,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 25,397
▼ 25% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 7,072
▲ € 5,572 vs 2024
Loans from banks and other lenders, long and short.
€ 198,903
▲ 15% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 65,978
▼ 20% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 307,783 | € 301,146 | € 428,676 | € 359,772 | ▼ 16% |
| Profit after taxes | € 54,507 | € 34,636 | € 73,860 | € 58,552 | ▼ 21% |
| Equity | € 247,208 | € 281,843 | € 305,704 | € 314,256 | ▲ 3% |
| Total debts | € 321,137 | € 314,397 | € 307,211 | € 322,870 | ▲ 5% |
| Cash | € 86,349 | € 77,079 | € 10,671 | € 14,988 | ▲ 40% |
| Retained profit | € 232,208 | € 266,843 | € 290,704 | € 299,256 | ▲ 3% |
| Dividend | € 0 | € 0 | € 50,000 | € 50,000 | |
| Bank debt | € 4,250 | € 4,625 | € 1,500 | € 7,072 | ▲ € 5,572 |
| Balance sheet total | € 568,345 | € 596,240 | € 612,914 | € 637,125 | ▲ 4% |
| Employees (FTE) | 3 | 3 | 3.9 | 4.1 | ▲ 0.2 |
Key figures of Geassocieerde Apotheek Schilde, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Geassocieerde Apotheek Schilde?
What happened at Geassocieerde Apotheek Schilde in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- J. Mannaerts stepped down as director. NBB
- A. Pirlot stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 58,552 (▼ 21% vs 2024). Source: NBB ↗
- J. Mannaerts became a director. NBB
- A. Pirlot became a director. NBB
- New establishment in Schilde. KBO
- Start of the company according to the CBE. KBO
In short
From € 54,507 profit in 2022 to € 58,552 profit in 2025.
Paid € 87,168 in corporate taxes since 2022.
Best year ever: 2024, with € 73,860 profit.
On average € 87,700 of value added per employee in 2025.
A new publication or filing at Geassocieerde Apotheek Schilde? We notify you, reason included.
Follow Geassocieerde Apotheek SchildeDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of AFS, Apotheek Clessens comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Geassocieerde Apotheek SchildeThe shares are held by AFS (99%) and Apotheek Clessens (1%). It owns 2.3% of AFS itself.
Directors
According to the 2025 annual accounts
A. Pirlot
Director
Also active at: Apoteek't Groen Kruis, Sint-Gummarus Apotheek, AFS, Apotheek Clessens, Antwerp Port Pharmacy, APOTHEEK VAN BROEKHOVEN, GEASSOCIEERDE APOTHEEK EKEREN, GEASSOCIEERDE APOTHEEK VAN PUYVELDE +9 more
since 2023 · until 2029
J. Mannaerts
Director
Also active at: Geassocieerde Apotheek Plantijn, AFS, Apotheek Clessens, Antwerp Port Pharmacy, APOTHEEK VAN BROEKHOVEN, GEASSOCIEERDE APOTHEEK EKEREN, GEASSOCIEERDE APOTHEEK VAN PUYVELDE, GEASSOCIEERDE APOTHEEK VERBIST +7 more
since 2025 · until 2031
Shareholders
99%
Participations
2.3%
Establishments
Establishment units
Physical locations of this company
Turnhoutsebaan 77
2970 Schilde
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0872.283.386
- VAT number
- BE 0872.283.386
- Registered office
- Turnhoutsebaan 77, 2970 Schilde
- Names & denominations
- Geassocieerde Apotheek Schilde · G.A. SCHILDE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 March 2005
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Detailhandel in farmaceutische producten
Activiteiten van holdings
Managementactiviteiten van holdings
Holdings